Specific immune response in human skin carcinoma.

Area of Science:

• Immunology
• Dermatology
• Oncology

Background:

• Squamous cell carcinoma (SCC) is a common skin cancer.
• Understanding the host immune response to SCC is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the presence and nature of immunological reactivity against tumor cells in patients with squamous cell carcinoma of the skin.

Main Methods:

• Utilized multiple immunological assays including membrane and cytoplasmic immunofluorescence.
• Employed complement-dependent serum cytotoxicity and lymphocyte attack assays on cultured tumor cells.
• Conducted detailed histological examination and time-lapse video microscopy for one in-depth case.

Main Results:

• Eight out of nine (89%) SCC patients demonstrated immunological reactivity against their own tumor cells.
• Reactivity was observed through various tests using patient sera and peripheral blood lymphocytes.
• One patient showed a strong positive response across all four tested immunological assays, with lymphocytes actively attacking cultured carcinoma cells.

Conclusions:

• The majority of squamous cell carcinoma patients exhibit immune responses directed at their tumor cells.
• These findings suggest a potential role for immunotherapy in treating SCC.
• Further research into the mechanisms of anti-SCC immunity could lead to novel therapeutic strategies.